4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2017 / Randomized crossover trial
A randomized, double-blind crossover trial examined 48 physically active men given either 500 mg of grape and apple polyphenols or a placebo prior to intense exercise testing. Ingestion of the polyphenols significantly increased time to exhaustion during a maximal endurance test by 9.7% ± 6.0% (p < 0.05). Additionally, participants reached their maximal perceived exertion 12.8% ± 6.8% later compared to the placebo condition (p < 0.05).
Deley G, Guillemet D, Allaert FA, et al. Nutrients, 2017. PMID 28829368
2013 / Randomized controlled trial
A randomized controlled trial assigned men over age 45 with lower urinary tract symptoms to 240 ml daily of 100% Concord grape juice or placebo for 3 months (96 completed). The primary symptom score improved identically in both groups by 1.6 points. No significant differences appeared for PSA, quality of life, or antioxidant correlations.
Spettel S, Chughtai B, Feustel P, et al. Neurourol Urodyn, 2013. PMID 22907790
2011 / Randomized crossover trial
Ten trained male athletes consumed isocaloric amounts of either sun-dried raisins or sports jelly beans every 20 minutes during 120 minutes of cycling. Subsequent 10-km time trial completion times (17.3 ± 0.4 seconds) and power output (229.3 ± 13.0 vs. 232.0 ± 13.6 W) did not differ between carbohydrate sources. Sensory acceptance ratings were significantly higher for raisins than for sports jelly beans (50.7 ± 1.7 vs. 44.3 ± 2.7).
Rietschier HL, Henagan TM, Earnest CP, et al. J Strength Cond Res, 2011. PMID 21881533
2009 / Randomized controlled trial
Twenty children aged 7 to 11 years consumed raisins, bran flakes, commercial raisin bran cereal, and experimental raisin bran cereal in a randomized trial. All test foods lowered plaque pH over 30 minutes, but commercial raisin bran produced the greatest reduction at 10 minutes (P < .001). Consuming raisins or experimental raisin bran never decreased plaque pH below 6 during testing.
Utreja A, Lingström P, Evans CA, et al. Pediatr Dent, 2009. PMID 20108741
2007 / Cross-sectional survey
A cross-sectional survey evaluated 690 children aged 7-18 years in rural Crete using parent-completed symptom and food frequency questionnaires along with skin prick tests. High consumption of grapes, oranges, apples, and fresh tomatoes showed no link with atopy but was protective for wheezing and rhinitis. High nut consumption was inversely linked to wheezing (OR 0.46; 95% CI 0.20 to 0.98), while margarine was linked to higher risk of wheeze (OR 2.19; 95% CI 1.01 to 4.82) and allergic rhinitis (OR 2.10; 95% CI 1.31 to 3.37). High adherence to a Mediterranean diet was inversely associated with allergic rhinitis (OR 0.34; 95% CI 0.18 to 0.64), with more modest protection observed for wheezing and atopy.
Shows an association, not proof of cause and effect.
Chatzi L, Apostolaki G, Bibakis I, et al. Thorax, 2007. PMID 17412780
2015 / Narrative review
This review examined available evidence on the effects of red wine on postprandial-induced metabolic and oxidative stress in humans. Following red wine consumption with a meal, non-enzymatic antioxidant capacity and lipoperoxidation markers improved, but confounding factors like increases in uric acid must be considered. Furthermore, ethanol-induced increases in both uric acid and triglycerides could cause liver damage. The authors concluded that inconsistent and contrasting findings exist regarding the benefits of red wine on postprandial stress.
Peluso I, Manafikhi H, Reggi R, et al. Eur J Nutr, 2015. PMID 25772634
2011 / Narrative review
This review examines nutrapharmacology and the therapeutic potential of resveratrol, a polyphenol found in grape skins and other plants, for targeting aging and obesity-related chronic diseases. It evaluates laboratory findings on inflammation and oxidative stress alongside published human pharmacokinetic and pharmacodynamic data. The authors note key obstacles to clinical use, including a lack of clinical evidence to date, a myriad of available doses and formulations, conflicting data on capsules versus food forms, and uncertain effects of long-term dosing.
Chachay VS, Kirkpatrick CM, Hickman IJ, et al. Br J Clin Pharmacol, 2011. PMID 21410504